199
Views
6
CrossRef citations to date
0
Altmetric
Patent Evaluations

New selective inhibitors of MMP-13 for inflammatory diseases: a patent evaluation (W02012151158)

, &
Pages 669-675 | Published online: 19 Mar 2013

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Elena Lenci, Lucrezia Cosottini & Andrea Trabocchi. (2021) Novel matrix metalloproteinase inhibitors: an updated patent review (2014 - 2020). Expert Opinion on Therapeutic Patents 31:6, pages 509-523.
Read now
Nian-Guang Li, Yu-Ping Tang, Jin-Ao Duan & Zhi-Hao Shi. (2014) Matrix metalloproteinase inhibitors: a patent review (2011 – 2013). Expert Opinion on Therapeutic Patents 24:9, pages 1039-1052.
Read now

Articles from other publishers (4)

Zhengqing Zhu, Lei Zhong, Ronghang Li, Yuzhe Liu, Xiangrun Chen, Zhaoyan Li & Lanfeng Huang. (2020) Study of Osteoarthritis-Related Hub Genes Based on Bioinformatics Analysis. BioMed Research International 2020, pages 1-10.
Crossref
Wei Zhang, Chi Zhang, Congfeng Luo, Yulin Zhan & Biao Zhong. (2019) Design, cyclization, and optimization of MMP13–TIMP1 interaction-derived self-inhibitory peptides against chondrocyte senescence in osteoarthritis. International Journal of Biological Macromolecules 121, pages 921-929.
Crossref
Charles J. Malemud. 2017. Matrix Metalloproteinases and Tissue Remodeling in Health and Disease: Target Tissues and Therapy. Matrix Metalloproteinases and Tissue Remodeling in Health and Disease: Target Tissues and Therapy 305 325 .
Roosmarijn E. Vandenbroucke & Claude Libert. (2014) Is there new hope for therapeutic matrix metalloproteinase inhibition?. Nature Reviews Drug Discovery 13:12, pages 904-927.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.